XML 11 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Changes in Stockholders' Equity (Unaudited) - USD ($)
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Other Comprehensive Income [Member]
Balance, shares at Dec. 31, 2020     62,410,452      
Balance, amount at Dec. 31, 2020 $ 11,250 $ 0 $ 6,241 $ 416 $ 4,593 $ 0
Accretion of stock-based compensation 10,433 0 0 10,433 0 0
Net loss (66,551) 0 $ 0 0 (66,551) 0
Balance, shares at Mar. 31, 2021     62,410,452      
Balance, amount at Mar. 31, 2021 (44,868) 0 $ 6,241 10,849 (61,958) 0
Accretion of stock-based compensation 15,134 0 0 15,134 0 0
Net loss (1,874,307) 0 0 0 (1,874,307) 0
Issuance of stock warrants for development of product (1,399,833) 0 $ 0 1,399,833 0 0
Recapitalization of the Company, shares     33,203,512      
Recapitalization of the Company, amount (84,225) $ 0 $ 3,320 (87,545) 0 0
Series D preferred stock issued for cash and settlement of accounts payable, shares   440,125        
Series D preferred stock issued for cash and settlement of accounts payable, amount 6,601,745 $ 44 $ 0 6,601,701 0 0
Exercised option and warrants, shares     1,175,500      
Exercised option and warrants, amount 150,345 0 $ 118 150,227 0 0
Issuance of common stock for license rights, shares     1,602,282      
Issuance of common stock for license rights, amount 1,073,529 $ 0 $ 160 1,073,369 0 0
Balance, shares at Jun. 30, 2021   440,125 98,391,746      
Balance, amount at Jun. 30, 2021 7,237,186 $ 44 $ 9,839 9,163,568 (1,936,265) 0
Accretion of stock-based compensation 60,585 0 0 60,585 0 0
Net loss (551,959) 0 $ 0 0 (551,959) 0
Exercised option and warrants, shares     3,783,333      
Exercised option and warrants, amount 1,134,999 $ 0 $ 377 1,134,622 0 0
Conversion of convertible preferred shares into common stock, shares   (412,853) 20,642,667      
Conversion of convertible preferred shares into common stock, amount 0 $ (41) $ 2,064 (2,023) 0 0
Balance, shares at Sep. 30, 2021   27,272 122,817,746      
Balance, amount at Sep. 30, 2021 7,880,811 $ 3 $ 12,281 10,356,751 (2,488,224) 0
Balance, shares at Dec. 31, 2021   27,272 125,317,746      
Balance, amount at Dec. 31, 2021 12,327,085 $ 3 $ 12,531 15,474,566 (3,160,015) 0
Accretion of stock-based compensation 97,558 0 0 97,558 0 0
Net loss (872,858) $ 0 $ 0 0 (872,858) 0
Conversion of Preferred Shares to Common Shares, shares   (27,272) 1,363,149      
Conversion of Preferred Shares to Common Shares, amount (2) $ (3) $ 136 (135) 0 0
Balance, shares at Mar. 31, 2022     126,680,895      
Balance, amount at Mar. 31, 2022 11,551,783 $ 0 $ 12,667 15,571,989 (4,032,873) 0
Balance, shares at Dec. 31, 2021   27,272 125,317,746      
Balance, amount at Dec. 31, 2021 $ 12,327,085 $ 3 $ 12,531 15,474,566 (3,160,015) 0
Exercised option and warrants, shares 0          
Conversion of Preferred Shares to Common Shares, shares 1,363,149          
Balance, shares at Sep. 30, 2022     126,680,895      
Balance, amount at Sep. 30, 2022 $ 9,743,147 0 $ 12,667 15,894,426 (6,159,975) (3,971)
Balance, shares at Mar. 31, 2022     126,680,895      
Balance, amount at Mar. 31, 2022 11,551,783 0 $ 12,667 15,571,989 (4,032,873) 0
Accretion of stock-based compensation 138,912 0 0 138,912 0 0
Net loss (1,214,275) 0 0 0 (1,214,275) 0
Foreign currency gain (loss) (771) 0 0 0 0 (771)
Unrealized gain (loss) on investments (11,243) 0 $ 0 0 0 (11,243)
Balance, shares at Jun. 30, 2022     126,680,895      
Balance, amount at Jun. 30, 2022 10,464,406 0 $ 12,667 15,710,901 (5,247,148) (12,014)
Accretion of stock-based compensation 183,524 0 0 183,524 0 0
Net loss (912,826) 0 0 0 (912,826) 0
Foreign currency gain (loss) (78) 0 0 0 0 (78)
Unrealized gain (loss) on investments 8,121 0 $ 0 0 0 8,121
Balance, shares at Sep. 30, 2022     126,680,895      
Balance, amount at Sep. 30, 2022 $ 9,743,147 $ 0 $ 12,667 $ 15,894,426 $ (6,159,975) $ (3,971)